Prostate cancer diagnosis and therapy, Starting to integrate AI for treatment decisions in oncology. | Nature Portfolio Cancer Community
With new research showing that CoQ10 may also program cancer cells to self-destruct, this nutrient may become an invaluable adjuvant therapy for cancer patients. Scientifically reviewed by: Dr. Gary GonzalezMD, on January
It has the potential to reduce false negatives and speed up diagnosis, which can make a life-saving difference to patients. Prostate biopsy, the most reliable method of detection, is a challenge because of the difficulties in visualizing not only the entirety of the prostate, but also the location of the biopsy needle.
New aspect of photodynamic diagnosis of bladder tumors: The fluorescence cytology. Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer.
Trans-rectal ultrasound-guided prostate biopsy TRUSthe current biopsy standard, commonly suffers from poor image resolution, and the biopsy needle often passes through tumor-free areas of the prostate — potentially missing the tumor entirely. UroNav — image-guided prostate biopsies UroNav is an image-guided stereotactic biopsy system used to detect prostate cancer within patients as an alternative to current blind or blind systematic biopsies.
News Prostate cancer In order to investigate the anticancer effect of DDW in humans a four-month long double-blind phase 2 placebo controlled clinical trial was conducted on prostate cancer. Forty-four patients were evaluated, 22 patients were involved in the treated- and 22 patients in the placebo group, both groups received the same forms of conventional treatment. During the extended follow-up of the 44 patients, in the first year from the date of entering the trial2 patients 9.
It uses multi- parametric magnetic resonance mpMR imaging, fused with live ultrasound US guidance in conjunction with electromagnetic EM tracking to plan, guide, and document prostate biopsies. UroNav simultaneously displays registered MR and ultrasound images and the projected needle path relative to the suspicious target lesion during the biopsy procedure and guides the urologist in real-time.
Earlier diagnosis —the pathway to better outcomes This novel approach has the ability to improve the sensitivity and specificity of prostate biopsies.
This results in a reduced incidence rate of false negative biopsy results. By enabling earlier diagnosis, UroNav allows a broader array of treatment options to be considered by the clinician, less complications for the patient, and a more cost-effective resolution for the care provider.
From set up to post-biopsy review, UroNav guides you through its intuitive workflow. After a quick initialization of the navigation system upper imageProstate cancer diagnosis and therapy creates a 3D ultrasound volume from a standard 2D scan of the prostate lower image.
Clinical studies Clinical studies are being carried out by clinical partners, including Dr. For more information Access clinical studies about UroNav.